Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Clinical trial NCT00006364 · COMPLETED

Trial details

NCT number: NCT00006364
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Childhood Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Relapsing Chronic Myelogenous Leukemia

Start date: 1999-11-01
Primary completion: 2005-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.